In vivo hypolipidemic effects and safety of low dosage Monascus powder in a hamster model of hyperlipidemia

Applied Microbiology and Biotechnology

Volumn 70, Issue 5, 2006, Pages 533-540

  Lee, Chun Lin ^a   Tsai, Tsung Yu ^a   Wang, Jyh Jye ^b   Pan, Tzu Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAJEN INSTITUTE OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPSY; CHOLESTEROL; CROPS; FOOD ADDITIVES; LIPIDS; METABOLITES; PLASMAS; PRODUCTIVITY; PROTEINS;

ANTIHYPERCHOLESTEROLEMIC AGENT; HYPERLIPIDEMIA; HYPOLIPIDEMIC EFFECTS; MONASCUS POWDER;

POWDERS;

CITRININ; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN;

FERMENTATION; GROWTH; LIPID; METABOLITE; RICE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; DIET; DRUG EFFECT; HAMSTER; HYPERLIPIDEMIA; HYPOLIPEMIA; LIPID LIVER LEVEL; LIVER BIOPSY; LIVER INJURY; LIVER TOXICITY; MALE; MONASCUS; MONASCUS PURPUREUS; MOULD; NEPHROTOXICITY; NONHUMAN; SAFETY; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTILIPEMIC AGENTS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CRICETINAE; DISEASE MODELS, ANIMAL; HYPERLIPIDEMIAS; LIVER; LIVER DISEASES; MALE; MESOCRICETUS; MONASCUS; PHYTOTHERAPY; PLANT EXTRACTS; POWDERS; TRIGLYCERIDES;

FOOD ADDITIVES; LIPIDS; PLASMA; POWDER; PROTEINS; RICE; STEROLS;

ASIA; CHINA; EURASIA; FAR EAST;

ANIMALIA; CRICETINAE; MONASCUS; MONASCUS PURPUREUS;

EID: 33645710463     PISSN: 01757598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00253-005-0137-0     Document Type: Article

References (29)

1. Aguilera CM, Ramirez-Tortosa CL, Quiles JL, Yago MD, Martinez-Burgos MA, Martinez-Victoria E, Gil A, Ramirez-Tortosa MC (2005) Monounsaturated and omega-3 but not omega-6 polyunsaturated fatty acids improve hepatic fibrosis in hypercholesterolemic rabbits. Nutrition 21:363-371
2. Albert AW, Chen J, Springer J (1980) Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol lowering agent. Proc Natl Acad Sci U S A 77:3957-3961
3. American Institute of Nutrition (1977) Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies. J Nutr 107:1340-1348
4. Aniya Y, Ohtani II, Higa T, Miyagi C, Gibo H, Shimabukuro M, Nakanish H, Taira J (1999) Dimerumic acid as an antioxidant of the mold, Monascus anka. Free Radic Biol Med 286:999-1004
5. Blanc PJ, Laussac JP, Le Bars J, Le Bars P, Loret MO, Pareilleux A, Prome D, Prome JC, Santerre AL, Goma G (1995a) Characterization of monascidin A from Monascus as citrinin. Int J Food Microbiol 27:201-213
6. Blanc PJ, Loret MO, Goma G (1995b) Production of citrinin by various species of Monascus. Biotechnol Lett 17:291-294
7. Boyd E (1935) The growth of the surface area of human body. University of Minnesota Press, Minneapolis
8. Casas López JL, Sánchez Pérez JA, Fernández Sevilla JM, Acién Fernández FG, Molina Grima E, Chisti Y (2003) Production of lovastatin by Aspergillus terreus: effects of the C:N ratio and the principal nutrients on growth and metabolite production. Enzyme Microb Technol 33:270-277
9. Chang YN, Lin YC, Lee CC, Liu BL, Tzeng YM (2002) Effect of rice-glycerol complex medium on the production of lovastatin by Monascus ruber. Folia Microbiol (Praha) 47:677-684
10. Da Lozzo EJ, Oliveira MBM, Carnieri EGS (1998) Citrinin-induced mitochondrial permeability transition. J Biochem Mol Toxicol 12:291-297
11. Endo A (1979) Monacolin K, a new hypocholesterolemic agent produced by Monascus species. J Antibiot 32:852-854
12. Endo A, Hasumi K, Negishi S (1985) Monacolins J and L, new inhibitors of cholesterol biosynthesis produced by Monascus ruber. J Antibiot 38:420-422
13. Havel RJ, Hunninghake DB, Illingworth DR (1987) Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study. Ann Intern Med 107: 609-615
14. Hsieh YT, Pan TM (2002) The analytic methods and assays for secondary metabolites of Monascus products. J Biomass Energy Soc China 21:63-71
15. Jeong WI, Jeong DH, Do SH, Kim YK, Park HY, Kwon OD, Kim TH, Jeong KS (2005) Mild hepatic fibrosis in cholesterol and sodium cholate diet-fed rats. J Vet Med Sci 67:235-242
16. Lai LT, Pan CC, Tzeng BK (2003) The influence of medium design on lovastatin production and pellet formation with a high-producing mutant of Aspergillus terreus in submerged cultures. Proc Biochem 38:1317-1326
17. Lee CL, Wang JJ, Shing LK, Pan TM (2005) Study on the character and function of high monacolin K productivity mutant - Monascus purpureus NTU568. (Submitted to J Agric Food Chem)
18. Li CL, Zhu Y, Wang YY, Zhu JS, Chang J, Kritchevsky D (1998) Monascus purpureus-fermented rice (red yeast rice): a natural food product that lowers blood cholesterol in animal models of hypercholesterolemia. Nutr Res 18:71-81
19. Manzoni M, Rollini M (2002) Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs. Appl Microbiol Biotechnol 58:555-564
20. Manzoni M, Bergormi S, Rollini M, Cavazzoni V (1999) Production of statins by filamentous fungi. Biotechnol Lett 21:253-257
21. Michihara A, Sawamura M, Yamori Y, Akasaki K, Tsuji H (2003) Probucol decreases mevalonate pyrophosphate decarboxylase in the rat liver. Biol Pharm Bull 26:1484-1486
22. Noto H, Kawamura M, Hashimoto Y, Satoh H, Hara M, Iso-o N, Togo M, Kimura S, Tsukamoto K (2003) Modulation of HDL metabolism by probucol in complete cholesteryl ester transfer protein deficiency. Atherosclerosis 171:131-136
23. Papadia FS, Marinari GM, Camerini G, Murelli F, Carlini F, Stabilini C, Scopinaro N (2004) Liver damage in severely obese patients: a clinical-biochemical-morphologic study on 1,000 liver biopsies. Obes Surg 14:952-958
24. Schneweis I, Meyer K, Hormansdorfer S, Bauer J (2001) Metabolites of Monascus ruber in silages. J Anim Physiol Anim Nutr 85:38-44
25. Su YC, Wang JJ, Lin TT, Pan TM (2003) Production of the secondary metabolites γ-aminobutyric acid and monacolin K by Monascus. J Ind Microbiol Biotech 30:40-46
26. Wang UL, Houng JY, Chang HS, Chien CR, Hsu WH (1998) Selection of drug-resistant mutants Monascus pilosus for enhanced monacolin K production. J Chin Agric Chem Soc 36:192-200
27. Wang JJ, Lee CL, Pan TM (2003) Improvement of monacolin K, γ-aminobutyric acid and citrinin production ratio as a function of environmental conditions of Monascus purpureus NTU 601. J Ind Microbiol Biotech 30:669-676
28. Wong HC, Koehler PE (1981) Production and isolation of an antibiotic from Monascus purpureus and its relationship to pigment production. J Food Sci 46:589-592
29. Wu GF, Wu XC (2000) Screening DPPH radical scavengers from Monascus sp. Acta Microbiol Sin 40:394-399